KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 66 filers reported holding KALEIDO BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,543,000 | -31.0% | 6,389,660 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,270,000 | -56.2% | 6,389,152 | +0.0% | 0.00% | -66.7% |
| Q3 2021 | $34,871,000 | -26.5% | 6,386,629 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $47,451,000 | -8.0% | 6,377,797 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $51,597,000 | +53.6% | 6,370,018 | +72.5% | 0.00% | +33.3% |
| Q4 2020 | $33,602,000 | -3.7% | 3,692,559 | +17.2% | 0.00% | -25.0% |
| Q3 2020 | $34,884,000 | +72.9% | 3,151,259 | +16.1% | 0.00% | +100.0% |
| Q2 2020 | $20,170,000 | +44.1% | 2,714,722 | +19.3% | 0.00% | 0.0% |
| Q1 2020 | $13,997,000 | +33.6% | 2,276,007 | +9.1% | 0.00% | +100.0% |
| Q4 2019 | $10,476,000 | -29.2% | 2,086,907 | +6.2% | 0.00% | -50.0% |
| Q3 2019 | $14,801,000 | -32.4% | 1,965,624 | +2.1% | 0.00% | -33.3% |
| Q2 2019 | $21,895,000 | -12.9% | 1,925,007 | +6.4% | 0.00% | 0.0% |
| Q1 2019 | $25,143,000 | – | 1,809,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 17,360,710 | $106,768,000 | 5.00% |
| HARBOURVEST PARTNERS LLC | 1,167,166 | $7,178,000 | 3.46% |
| Palo Alto Investors LP | 787,999 | $4,846,000 | 0.41% |
| Artal Group S.A. | 500,500 | $3,078,000 | 0.13% |
| BAINCO INTERNATIONAL INVESTORS | 22,037 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $656,000 | 0.02% |
| Baillie Gifford | 440,000 | $2,706,000 | 0.00% |
| FMR LLC | 2,276,007 | $13,997,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 250,372 | $1,540,000 | 0.00% |